VMI
VHCP Management II Portfolio holdings
AUM
$379M
This Quarter Return
-12.35%
1 Year Return
+424.39%
3 Year Return
+2,335.22%
5 Year Return
–
10 Year Return
–
AUM
$233M
AUM Growth
+$233M
(-38%)
Cap. Flow
-$93.7M
Cap. Flow
% of AUM
-40.23%
Top 10 Holdings %
Top 10 Hldgs %
91.29%
Holding
24
New
3
Increased
2
Reduced
1
Closed
5
Top Buys
Top Sells
1 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$74.8M |
2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$10.3M |
3 |
argenx
ARGX
|
$9.19M |
4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$6.91M |
5 |
Apellis Pharmaceuticals
APLS
|
$528K |
Sector Composition
1 | Healthcare | 97.66% |